Study identifies new disease-inducing mechanism for inflammatory bowel disease
Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK
Read More
Tag: Newcastle University
New collaboration aims to research early mutations in rare blood disorder
Langerhans cell histiocytosis currently affects around one in 200,000 children in the UK
Read More
Ten-minute brain scan could improve diagnosis for paediatric brain cancer
Medulloblastoma is responsible for around 52 new cases in children in the UK every year
Read More
Researchers identify genetic changes responsible for rare childhood immune disorders
Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns
Read More
Researchers reveal people with Parkinson’s more likely to experience delirium in hospital
Two out of three people with the neurodegenerative condition experienced delirium in hospital
Read More
New clinical study to advance development of treatments for liver cirrhosis
The £30m ADVANCE study is the most extensive study into liver disease worldwide
Read More
Lewy Body Society grants £1 million for dementia research
The Lewy Body Society has announced that the latest recipients of its grant programme will be University of Cambridge, Newcastle University and Imperial College London.
Read More
New research aims to help prevent sight loss for children with eye cancer
Fight for Sight has announced funding for vital research that could help save the sight of children with retinoblastoma.
Read More
CR UK, Newcastle Uni extend alliance with Astex
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals by three years to work on developing new cancer drugs and associated biomarkers.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
